Search Results pdgf
1.
BioMimetic Therapeutics Reports Patent Allowance from U.S. Patent and Trademark Office for PDGF Compositions Patent
...from U.S. Patent and Trademark Office for PDGF Compositions Patent WIRELESS NEWS-November...from U.S. Patent and Trademark Office for PDGF Compositions Patent (C)2008 10Meters...compositions of platelet derived growth factor (PDGF) combined with matrix materials having...
November 29, 2008; Wireless News
2.
United States Department of Health & Human Services obtains United States patent.(for Platelet-Derived Growth Factor (PDGF) receptor )(Brief Article)
...patented human Platelet- Derived Growth Factor (PDGF) receptor protein free of other PDGF receptors. These proteins can be produced from...level of expression of genes for specific types of PDGF receptor proteins, for example, by measuring mRNA...
January 1, 2004; BIOTECH Patent News
3.
CuraGen Discovers Novel Growth Factor in PDGF Family.
...new member of the platelet-derived growth factor (PDGF) family that has been named PDGF-D. This newly discovered protein occurs naturally...antibodies into therapeutics to treat human disease. PDGF-D is over-expressed in renal and ovarian cancers...
May 8, 2001; PR Newswire
4.
PDGF
PDGF Med., Biochem. platelet-derived growth factor
January 1, 1998; The Oxford Dictionary of Abbreviations
5.
BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent.
...compositions of platelet derived growth factor (PDGF) combined with matrix materials having...exclude potential competitors from marketing PDGF containing products similar to ours containing critical formulations and dosages of PDGF until at least 2024. Allowance of this...
November 21, 2008; Business Wire
6.
BioMimetic Pharmaceuticals and ZymoGenetics Sign Second Licensing Agreement for Clinical Development and Commercialization of PDGF.
...tissues, under ZymoGenetics' broad patent portfolio for PDGF. Recombinant human PDGF is a therapeutic protein with potent growth stimulatory...BMPI is well positioned to continue development of PDGF for other hard tissue defects and therapies, commented...
February 6, 2003; Business Wire
7.
Therapy of hypereosinophilic syndrome, polycythemia vera, atypical CML or CMML with PDGF-R fusion genes, or mastocytosis with Gleevec.(CLINICAL TRIAL REVIEW)
...can improve the disease condition in patients with hypereosinophilic syndrome, polycythemia vera, atypical CML or CMML with PDGF-R fusion genes, or mastocytosis. Condition Treatment or Intervention Phase Chronic Drug: Gleevec[R] Phase II myelomonocytic...
March 1, 2005; Journal of Drugs in Dermatology
8.
ZymoGenetics and BioMimetic Pharmaceuticals Sign Licensing Agreement for Clinical Development of PDGF.
...rhPDGF). BMPI will focus on the use of PDGF for the treatment of periodontal disease...ZymoGenetics' broad patent portfolio for PDGF, a therapeutic protein with potent growth...the company is well positioned to develop PDGF for the treatment of periodontal disease...
June 5, 2001; PR Newswire
9.
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program.
...Ophthotech Corporation to divest its anti-platelet derived growth factor (PDGF) aptamer program. Under the terms of the agreement, OSI will transfer to Ophthotech all rights in the PDGF aptamer program, including rights to its pre-clinical compound E10030...
July 27, 2007; Wire
10.
Chiron and Johnson & Johnson to Proceed with PDGF for Wound Healing.
EMERYVILLE, CalifBUSINESS WIRESept. 18, 1995--Chiron Corporation (NASDAQ: CHIR) announced today that the company and Johnson & Johnson have reviewed favorable preliminary Phase 3 clinical trial data on their wound healing agent Regranex (becaplermin), a formulation containing recombinant human
September 18, 1995; Business Wire
|
